Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ONC
ONC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ONC News
BeOne's Drug Shows New Breakthroughs in CLL Treatment
2d ago
Newsfilter
TEVIMBRA and ZIIHERA Combination Therapy Significantly Improves Survival Rates
3d ago
Newsfilter
BeOne Medicines to Participate in Goldman Sachs Healthcare Conference
5d ago
Newsfilter
BeOne Medicines Showcases New Advances at ASCO
May 21 2026
Newsfilter
BeOne Launches Soccer Campaign to Enhance Cancer Care
May 20 2026
Newsfilter
BeOne's Drug Receives FDA Accelerated Approval
May 13 2026
stocktwits
BeOne Medicines Receives FDA Accelerated Approval for Beqalzi
May 13 2026
seekingalpha
FDA Grants Accelerated Approval for BEQALZI as New BCL2 Inhibitor
May 13 2026
Newsfilter
BeOne Medicines AG Q1 2026 Earnings Call Highlights
May 06 2026
seekingalpha
BeiGene Q1 2026 Earnings Exceed Expectations with Strong Revenue Growth
May 06 2026
seekingalpha
Latest Wall Street Rating Updates
May 04 2026
CNBC
TEVIMBRA and ZIIHERA Combination Therapy Significantly Improves Survival Rates
Apr 29 2026
Newsfilter
BeiGene to Announce Q1 Earnings on April 15
Apr 14 2026
seekingalpha
BeOne Medicines Receives Conditional Approval for Lung Cancer Treatment in China
Apr 10 2026
seekingalpha
BEONE MEDICINES: TRUIST SECURITIES LOWERS TARGET PRICE TO $411, DOWN FROM $412
Apr 08 2026
moomoo
BeOne Medicine's BGB-B2033 Receives FDA Orphan Drug Designation
Mar 23 2026
seekingalpha
Show More News
